Personalized phage therapy to fight AMR infections

Our personalized phage therapy solutions were tested in >100 critically ill patients with a success rate > 70% and no serious side effects.

Fast selection of therapeutic phages at the hospital – Phages pre-produced and delivered within 24 to 48h to the patient

Technology:
  • Antimicrobial compound/strategy
  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Validation
  • Market entry
  • Research
  • Development
  • Marketed product

Organization:
  • Company
  • Academia
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • CARB-X
  • FIND
  • GARDP
  • REPAIR
  • OTHER / NA

Infectious disease area:
  • UTI
  • BSI
  • RTI
  • SSTI
  • IAI
  • SSI
  • STI
  • GII
  • CNSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


We fight AMR infections with personalized phage therapy solutions (automated diagnostic tool with a library of phages that we can produce).

N.A.


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed